Modern Chinese Medicine Unit to Acquire Sun Xinlei’s Entire Stake in Chengde Yushi Jindan Pharmaceutical

PUBT · 2d ago
Modern Chinese Medicine Unit to Acquire Sun Xinlei’s Entire Stake in Chengde Yushi Jindan Pharmaceutical
  • Modern Chinese Medicine Group’s wholly-owned subsidiary Shijiazhuang Medical Research Advisory will acquire Sun Xinlei’s entire stake in Chengde Yushi Jindan Pharmaceutical.
  • The parties also agreed to unwind contractual arrangements governing the business, according to the October 21, 2026, announcement.
  • The transaction follows the 2024 Catalogue’s removal of foreign investment restrictions on manufacturing, including traditional Chinese medicine production.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Modern Chinese Medicine Group Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261021-12378208), on October 21, 2026, and is solely responsible for the information contained therein.